Gt Biopharma, INC. 8-K Filing
Ticker: GTBP · Form: 8-K · Filed: Jan 27, 2025 · CIK: 109657
Sentiment: neutral
Filing Stats: 491 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-01-27 07:00:36
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value GTBP The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-2.htm (EX-99.2) — 20KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- ex99-2_001.jpg (GRAPHIC) — 549KB
- ex99-2_002.jpg (GRAPHIC) — 1702KB
- ex99-2_003.jpg (GRAPHIC) — 1058KB
- ex99-2_004.jpg (GRAPHIC) — 815KB
- ex99-2_005.jpg (GRAPHIC) — 1187KB
- ex99-2_006.jpg (GRAPHIC) — 943KB
- ex99-2_007.jpg (GRAPHIC) — 776KB
- ex99-2_008.jpg (GRAPHIC) — 735KB
- ex99-2_009.jpg (GRAPHIC) — 787KB
- ex99-2_010.jpg (GRAPHIC) — 611KB
- ex99-2_011.jpg (GRAPHIC) — 741KB
- ex99-2_012.jpg (GRAPHIC) — 892KB
- ex99-2_013.jpg (GRAPHIC) — 540KB
- ex99-2_014.jpg (GRAPHIC) — 800KB
- ex99-2_015.jpg (GRAPHIC) — 695KB
- ex99-2_016.jpg (GRAPHIC) — 1060KB
- ex99-2_017.jpg (GRAPHIC) — 589KB
- ex99-2_018.jpg (GRAPHIC) — 314KB
- ex99-2_019.jpg (GRAPHIC) — 1074KB
- ex99-2_020.jpg (GRAPHIC) — 1111KB
- ex99-2_021.jpg (GRAPHIC) — 651KB
- ex99-2_022.jpg (GRAPHIC) — 919KB
- ex99-2_023.jpg (GRAPHIC) — 1349KB
- ex99-2_024.jpg (GRAPHIC) — 674KB
- ex99-2_025.jpg (GRAPHIC) — 726KB
- 0001493152-25-003707.txt ( ) — 29542KB
- gtbp-20250127.xsd (EX-101.SCH) — 3KB
- gtbp-20250127_lab.xml (EX-101.LAB) — 33KB
- gtbp-20250127_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GT BIOPHARMA, INC. Date: January 27, 2025 By: /s/ Alan Urban Alan Urban Chief Financial Officer